Trade Cytokinetics Inc - CYTK CFD
Add to favourite- Summary
- Historical Data
Spread | 0.13 | ||||||||
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023374% | ||||||||
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001151% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 0.1 | ||||||||
Currency | USD | ||||||||
Margin | 5.00% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
Prev. Close | 46.66 |
Open | 47.85 |
1-Year Change | 29.92% |
Day's Range | 47.85 - 49.6 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Dec 20, 2024 | 48.84 | 2.34 | 5.03% | 46.50 | 50.06 | 46.50 |
Dec 19, 2024 | 46.66 | 0.28 | 0.60% | 46.38 | 47.20 | 45.64 |
Dec 18, 2024 | 46.22 | -1.62 | -3.39% | 47.84 | 49.20 | 45.94 |
Dec 17, 2024 | 47.70 | -0.60 | -1.24% | 48.30 | 48.84 | 47.32 |
Dec 16, 2024 | 48.96 | 0.66 | 1.37% | 48.30 | 49.47 | 48.30 |
Dec 13, 2024 | 48.61 | -1.07 | -2.15% | 49.68 | 50.02 | 47.98 |
Dec 12, 2024 | 50.16 | -0.04 | -0.08% | 50.20 | 50.46 | 49.48 |
Dec 11, 2024 | 50.63 | 0.30 | 0.60% | 50.33 | 50.81 | 49.71 |
Dec 10, 2024 | 50.51 | 0.36 | 0.72% | 50.15 | 51.03 | 50.09 |
Dec 9, 2024 | 50.41 | -0.29 | -0.57% | 50.70 | 51.41 | 50.15 |
Dec 6, 2024 | 50.88 | 0.53 | 1.05% | 50.35 | 51.89 | 50.11 |
Dec 5, 2024 | 50.35 | 0.64 | 1.29% | 49.71 | 50.59 | 49.52 |
Dec 4, 2024 | 50.38 | -0.71 | -1.39% | 51.09 | 51.43 | 50.26 |
Dec 3, 2024 | 51.39 | 1.11 | 2.21% | 50.28 | 51.74 | 49.91 |
Dec 2, 2024 | 50.56 | 0.04 | 0.08% | 50.52 | 51.47 | 50.22 |
Nov 29, 2024 | 51.80 | -0.15 | -0.29% | 51.95 | 52.65 | 51.59 |
Nov 27, 2024 | 52.20 | 0.45 | 0.87% | 51.75 | 52.76 | 51.47 |
Nov 26, 2024 | 51.94 | 2.36 | 4.76% | 49.58 | 52.65 | 49.38 |
Nov 25, 2024 | 50.16 | 0.80 | 1.62% | 49.36 | 50.99 | 49.30 |
Nov 22, 2024 | 49.01 | 1.50 | 3.16% | 47.51 | 49.74 | 47.35 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Cytokinetics Inc Company profile
About Cytokinetics, Inc.
Cytokinetics, Incorporated is a late-stage biopharmaceutical company that is focused on discovering, developing and commercializing muscle activators and muscle inhibitors as potential treatments for debilitating diseases. The Company is developing small molecule drug candidates specifically engineered to impact muscle function and contractility. The Company is conducting METEORIC-HF, a second Phase III clinical trial of omecamtiv mecarbil. It is also developing aficamten, a cardiac myosin inhibitor, for the potential treatment of HCM. The Company also conducts research and development on novel treatments for disorders involving muscle function beyond muscle contractility. The Company’s lead drug candidates in clinical development are omecamtiv mecarbil, a cardiac myosin activator; CK-136, a cardiac troponin activator; reldesemtiv, a fast-skeletal muscle troponin activator (FSTA) and CK-3773274 (CK-274), a cardiac myosin inhibitor.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Cytokinetics, Inc. revenues increased 26% to $70.4M. Net loss increased 69% to $215.3M. Revenues reflect License revenues increase of 50% to $54.9M, Milestone revenues increase of 79% to $5M. Higher net loss reflects Research and development increase of 66% to $149.5M (expense), Other General and administrative increase of 91% to $80.4M (expense).
Equity composition
Common Stock $.001 Par, 02/11, 170M auth., 66,910,100 o/s. Insiders and Straegic holds 9.82%. 4/29/04, 5,800,000 shares @ $13 per share by Goldman, Sachs & Co. 25/13, 1-for-6 Reverse Stock split.
Industry: | Bio Therapeutic Drugs |
350 Oyster Point Boulevard
SOUTH SAN FRANCISCO
CALIFORNIA 94080
US
News
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
22:39, 12 December 2024Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
09:13, 6 December 2024Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
12:47, 5 December 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com